Sharaf E. Sharaf
Umm al-Qura University, University of Surrey
Research areas: Pharmacology, Toxicology and Pharmaceutics · Drug Discovery · Computational Drug Discovery Methods · Cholinesterase and Neurodegenerative Diseases · Alzheimer's disease research and treatments
0000-0002-0679-6586
About
Dr. Sharaf Ezzat Sharaf
Clinical Consultant in Clinical & Pharmaceutical Biochemistry
Associate Professor of Clinical Pharmaceutical Sciences
Department of Pharmaceutical Sciences – College of Pharmacy
Consultant & Member of Chartered Management Institute, the UK
Certified Trainer at the Technical and Vocational Training Corporation
Certified Trainer at SCFHS
BSc, MSc, & PhD
Umm Al-Qura University – Kingdom of Saudi Arabia
Employment
- 2010 - 2017
-
Umm Al-Qura University Associate Professor2007 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (32)
- Evaluating potential Leclercia adecarboxylata transfer RNA sulfurtransferase inhibitors as therapeutic targets via molecular docking and dynamics simulations Save
- Computational screening of repurposed drugs targeting lactoferrin for neurodegenerative diseases. Save
- Virtual screening and molecular dynamics simulations identify repurposed drugs as potent inhibitors of Histone deacetylase 1: Implication in cancer therapeutics Save
- Identifying Donepezil‐Like Compounds Against Acetylcholinesterase Using Molecular Docking, Dynamic Simulation, ADMET, and PCA: Therapeutic Management of Alzheimer’s Disease Save
- Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer’s drug discovery Save
- Evaluation of binding mechanism of dietary phytochemical, capsaicin, with human transferrin: targeting neurodegenerative diseases therapeutics Save
- Unlocking therapeutic potential: computational insights into TREM2 protein targeting with FDA-approved drugs for neurodegeneration Save
- G Protein-coupled Receptors (GPCRs) as Potential Therapeutics for Psychiatric Disorders Save
- Assessment of Knowledge, Attitude, and Practice of Therapeutic Drug Monitoring Among Hospital Pharmacists in Saudi Arabia Save
- Evaluating Adherence to Therapeutic Drug Monitoring Guidelines for Gentamicin in Neonatal Care: A Retrospective Study at the Maternity and Children’s Hospital in Makkah Save
- Targeting Sirtuin 1 for therapeutic potential: Drug repurposing approach integrating docking and molecular dynamics simulations Save
- Unveiling promising inhibitors of superoxide dismutase 1 (SOD1) for therapeutic interventions Save
- A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9 Save
- Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer’s Disease Save
- Identifying β-secretase 1 (BACE1) inhibitors from plant-based compounds: an approach targeting Alzheimer’s therapeutics employing molecular docking and dynamics simulation Save
- Computational insight into the binding of bryostatin 1 with ferritin: implication of natural compounds in Alzheimer’s disease therapeutics Save
- Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches Save
- Mechanistic Insight into the Binding of Huperzine a with Human Transferrin: Computational, Spectroscopic and Calorimetric Approaches Save
- Identification of 11-Hydroxytephrosin and Torosaflavone A as Potential Inhibitors of 3-Phosphoinositide-Dependent Protein Kinase 1 (PDPK1): Toward Anticancer Drug Discovery Save
- Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches Save